Maternal-fetal transmission of human parvovirus B19 genotype 3

Journal of Infectious Diseases

Volumn 194, Issue 5, 2006, Pages 608-611

  Candotti, Daniel ^a,c   Danso, Kwabena ^b   Parsyan, Armen ^a   Dompreh, Albert ^b   Allain, Jean Pierre ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^c Cambridge Blood Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS DNA;

ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CELL SPECIFICITY; GENOTYPE; GHANA; HUMAN; MATERNAL PLASMA; NONHUMAN; PARVOVIRUS; PLACENTAL TRANSFER; PRIORITY JOURNAL; SEROPREVALENCE; UMBILICAL CORD; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; INFANT, NEWBORN; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROEPIDEMIOLOGIC STUDIES; VIRAL LOAD;

EID: 33748081983     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/506450     Document Type: Article

References (15)

1. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002; 15:485-505.
2. Yaegashi N. Pathogenesis of nonimmune hydrops foetalis caused by intrauterine B19 infection. Tohoku J Exp Med 2000; 190:65-82.
3. Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76:9124-34.
4. Candotti D, Etiz N, Parsyan A, Allain J-P. Identification and characterization of persistent human erythrovtrus infection in blood donor samples. J Virol 2004; 78:12169-78.
5. Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989; 149:1153-6.
6. Dembinski J, Eis-Hübinger AM, Maar J, Schild R, Bartmann P. Long term follow up of serostatus after maternofetal parvovirus B19 infection. Arch Dis Child 2003; 88:219-21.
7. Lefrère J-J, Servant-Delmas A, Candotti D, et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 2005; 106:2890-5.
8. Saldanha J, Lelie N, Yu MW, Heath A, the B19 Collaborative Study Group. Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 2002; 82:24-31.
9. Parsyan A, Kerr S, Owusu-Ofori S, Elliott G, Allain J-P. Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol 2006; 44:1367-75.
10. Schoub BD, Blackburn NK, Johnson S, McAnerney JM. Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa. S Afr Med J 1993; 83:505-6.
11. Tolfvenstam T, Enbom M, Ghebrekidan H, et al. Seroprevalence of viral childhood infections in Eritrea. J Clin Virol 2000; 16:49-54.
12. Skjoldebrand-Sparre L, Fridell E, Nyman M, Wahren B. A prospective study of antibodies against parvovirus B19 in pregnancy. Acta Obstet Gynecol Scand 1996; 75:336-9.
13. Lindblom A, Isa A, Norbeck O, et al. Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 2005; 41:1201-3.
14. Norbeck O, Papadogiannakis N, Petersson K, Hirbod T, Broliden K, Tolfvenstam T. Revised clinical presentation of parvovirus B 19-associated intrauterine fetal death. Clin Infect Dis 2002; 35:1032-8.
15. Knöll A, Louwen F, Kochanowski B, et al. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol 2002; 67:259-66.